Adenocarcinoma of the prostate Trials in Baltimore, United States
Conditions / Adenocarcinoma of the prostate / Baltimore, United States
Adenocarcinoma of the prostate is a medical condition with active clinical research programs worldwide.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02225925 | Intraoperative Dosimetry for Prostate Brachytherapy Using Fluoroscopy and Ultrasound | COMPLETED | NA |
| NCT00109811 | Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer | COMPLETED | PHASE2 |
| NCT02203695 | Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy | COMPLETED | PHASE2 |
| NCT01270880 | Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy | COMPLETED | PHASE2 |
| NCT03535675 | Muscadine Plus (MPX) In Men With Prostate Cancer | TERMINATED | PHASE3 |
| NCT03686683 | Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer | COMPLETED | PHASE3 |
| NCT01517451 | Radiation and Androgen Ablation for Prostate Cancer | COMPLETED | PHASE1/PHASE2 |
| NCT00087139 | Ixabepilone in Treating Patients With Metastatic Prostate Cancer | COMPLETED | PHASE2 |
| NCT01949337 | Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer | UNKNOWN | PHASE3 |
| NCT01174199 | Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer | TERMINATED | PHASE1 |